ATE257648T1 - Definierte medizinische lösung ohne serum für die augenheilkunde - Google Patents

Definierte medizinische lösung ohne serum für die augenheilkunde

Info

Publication number
ATE257648T1
ATE257648T1 AT99308702T AT99308702T ATE257648T1 AT E257648 T1 ATE257648 T1 AT E257648T1 AT 99308702 T AT99308702 T AT 99308702T AT 99308702 T AT99308702 T AT 99308702T AT E257648 T1 ATE257648 T1 AT E257648T1
Authority
AT
Austria
Prior art keywords
supplements
nutrient
solution
growth factor
medical solution
Prior art date
Application number
AT99308702T
Other languages
English (en)
Inventor
Debra L Skelnik
Original Assignee
Debra L Skelnik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debra L Skelnik filed Critical Debra L Skelnik
Application granted granted Critical
Publication of ATE257648T1 publication Critical patent/ATE257648T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99308702T 1998-11-05 1999-11-02 Definierte medizinische lösung ohne serum für die augenheilkunde ATE257648T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/186,580 US6153582A (en) 1998-11-05 1998-11-05 Defined serumfree medical solution for ophthalmology

Publications (1)

Publication Number Publication Date
ATE257648T1 true ATE257648T1 (de) 2004-01-15

Family

ID=22685497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99308702T ATE257648T1 (de) 1998-11-05 1999-11-02 Definierte medizinische lösung ohne serum für die augenheilkunde

Country Status (9)

Country Link
US (1) US6153582A (de)
EP (1) EP1000541B1 (de)
JP (1) JP2000198701A (de)
AT (1) ATE257648T1 (de)
AU (1) AU769082B2 (de)
CA (1) CA2288540C (de)
DE (1) DE69914160T2 (de)
ES (1) ES2217700T3 (de)
PT (1) PT1000541E (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849612B2 (en) * 1993-01-21 2005-02-01 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
US6974796B1 (en) 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20070231402A1 (en) 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
US7790678B1 (en) 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
US20090274660A1 (en) 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6569615B1 (en) * 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
US7611830B2 (en) * 2000-04-10 2009-11-03 The United States Of America As Represented By The Department Of Veteran's Affairs Device to lavage a blood vessel
US6762053B2 (en) * 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
DE60140141D1 (de) * 2000-11-14 2009-11-19 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend Komplexe von Tocopherolphosphatderivaten
GB0028414D0 (en) 2000-11-22 2001-01-03 Univ Leeds Flush preservation solution
DE10133196A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Nicotinsäure enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
BR0211673A (pt) 2001-07-27 2004-07-13 Vital Health Sciences Pty Ltd Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
WO2003022046A1 (en) * 2001-09-10 2003-03-20 University Of Saskatchewan Technologies Inc. Method for cryopreserving mammalian cells and tissues
DE10295490D2 (de) * 2001-11-16 2004-12-23 Technocon Gmbh Verfahren zur Wasseraufbereitung
EP1478734A4 (de) * 2002-01-25 2006-04-05 Genzyme Corp Serumfreie medien für chondrozyten und verfahren zur verwendung davon
EP1480520A4 (de) * 2002-02-12 2006-02-15 Raven Biotechnologies Inc Epithelzellen aus der human-fötalen blase
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1475434A1 (de) * 2003-05-09 2004-11-10 Oncoscience AG Verfahren zur Lagerung von Tumorzellen
FR2856891B1 (fr) * 2003-07-04 2007-09-07 Stem Alpha Milieu de conservation d'organes, de tissus biologiques ou de cellules vivantes
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
JP4847437B2 (ja) 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
BRPI0400935A (pt) * 2004-04-02 2005-11-22 Ernesto Rodriguez Salas Solução para conservação de membranas biológicas e seu uso
JP2005306749A (ja) * 2004-04-19 2005-11-04 Kringle Pharma Inc Ｈｇｆ含有臓器保存液
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
WO2006092449A2 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
EP1868430B1 (de) * 2005-04-12 2015-07-08 Cleo Cosmetic and Pharmaceutical Co., LLC Zusammensetzung und verfahren zur in-vitro-konservierung von hornhautgewebe
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
CN100362098C (zh) * 2005-09-29 2008-01-16 华东理工大学 适用于多种动物细胞大规模培养的无血清培养基
US20070224588A1 (en) * 2006-03-22 2007-09-27 Biocept, Inc. Trophoblast preservation/pretreatment medium and method
EP2033513A1 (de) * 2006-05-30 2009-03-11 Instituto Nacional De Investigacion y Tecnologia agraria y Alimentaria (INIA) Vorgehensweise für die herstellung von unilamellaren vesikeln für die kryokonservierung und kultur von stammzellen und embryonen
CN100463681C (zh) * 2006-10-24 2009-02-25 北京紫竹药业有限公司 一种治疗干眼症的人工泪液
EP2543249B1 (de) * 2007-02-17 2018-05-23 President and Fellows of Harvard College Zusammensetzungen und verfahren zur Gewebekonservierung
EP2188367A4 (de) * 2007-08-10 2010-10-27 Whitehead Biomedical Inst Auf hormon ansprechendes gewebekultursystem und verwendungen davon
CA2715634A1 (en) 2008-02-15 2009-08-27 President And Fellows Of Harvard College Blood substitute solution
JP5663841B2 (ja) * 2009-02-23 2015-02-04 富士レビオ株式会社 骨細胞への分化誘導培地及び方法
CN101524063B (zh) * 2009-03-23 2012-06-13 姚晓明 角膜中期保存液
SG177613A1 (en) 2009-07-10 2012-03-29 Linzy O Scott Iii Methods and compositions for treating thyroid-related medical conditions with reduced folates
FR2948286B1 (fr) * 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
JP5681472B2 (ja) * 2009-12-28 2015-03-11 ロート製薬株式会社 眼科用組成物
EP2531047B1 (de) 2010-02-05 2024-11-13 Phosphagenics Limited Träger mit einem nichtneutralisierten tocopherylphosphat
EP2547760A4 (de) * 2010-02-17 2014-01-01 Hememics Biotechnologies Inc Konservierungslösungen für biologika und zugehörige verfahren
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
US9845457B2 (en) * 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
CN103797110B (zh) 2011-07-12 2017-08-25 食品安全测试系统公司 沙门氏菌和大肠杆菌的培养基和培养方法以及用于检测沙门氏菌和大肠杆菌的方法
EP3563859B1 (de) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Von kardiosphären abgeleitete exosomen zur geweberegeneration
WO2014070769A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
BR112015015090A2 (pt) * 2012-12-31 2017-07-11 Somahlution Llc processos para preservar a função de tecido ou de órgão e para preparar formulação para a mesma e kit respectivo
CN103190392B (zh) * 2013-03-28 2015-07-29 北京大学第三医院 一种角膜中期保存液及其制备方法
US10350232B1 (en) 2013-11-04 2019-07-16 Peter D. Jaillet Medicinal drops
CN105916374B (zh) 2013-11-22 2021-11-05 索玛解有限公司 用于增加器官和组织保存溶液的稳定性和储存寿命的溶液
EP4494699A3 (de) 2014-10-03 2025-04-30 Cedars-Sinai Medical Center Kardiosphären-zellen und durch diese zellen sekretierte exosomen bei der behandlung von muskeldystrophie
CN107206003B (zh) * 2014-12-02 2021-10-26 艾维德洛公司 用于眼的交联治疗的系统、方法和组合物
WO2016129654A1 (ja) * 2015-02-12 2016-08-18 国立大学法人 東京大学 角膜内皮前駆細胞の調製方法
ITUB20150108A1 (it) * 2015-03-04 2016-09-04 Alchilife S R L Molecola antimicotica sintetica e metodo per sintetizzare una molecola antimicotica
CA2981588A1 (en) 2015-04-03 2016-10-06 Tx Innovations B.V. Organ preservation composition
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
FR3040860B1 (fr) * 2015-09-10 2020-05-15 Universite de Bordeaux Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
IL267006B2 (en) 2016-12-21 2024-11-01 Phosphagenics Ltd Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof
US10265312B1 (en) * 2018-02-01 2019-04-23 Jason Ahee Antibiotic solution and method of injection to prevent ophthalmic infections
JP7336769B2 (ja) 2017-04-19 2023-09-01 シーダーズ―シナイ メディカル センター 骨格筋ジストロフィーを治療する方法及び組成物
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
EP3749344A4 (de) 2018-02-05 2022-01-26 Cedars-Sinai Medical Center Verfahren zur therapeutischen verwendung von exosomen und y-rnas
CN108841780B (zh) * 2018-06-29 2019-03-12 陕西诺威利华生物科技有限公司 适合大规模生产pedv疫苗的无血清培养基
CN109801994B (zh) * 2019-01-09 2020-11-24 成都中建材光电材料有限公司 一种提升碲化镉电池性能的方法
AU2020233397B2 (en) * 2019-03-04 2023-11-09 University Of Iowa Research Foundation Composition comprising an anti-oxidant to preserve corneal tissue
CN110278940A (zh) * 2019-07-11 2019-09-27 河南省农业科学院畜牧兽医研究所 一种猪精子保存剂及其制备方法和应用
EP4064837A4 (de) * 2019-11-29 2023-01-04 Rutgers, the State University of New Jersey Zusammensetzungen, kits und verfahren zur lagerung von blutprodukten und verwendungsverfahren dafür
EP4065690A4 (de) 2019-11-29 2022-10-05 Rutgers, the State University of New Jersey Verfahren zum isolieren von nabelblutplasmaprodukten, gewebe- und zellexosomen und zusammensetzungen und verfahren zur verwendung davon
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN112602703B (zh) * 2020-12-17 2022-05-27 中山大学附属第三医院 一种细胞、组织或器官冷保存液的制备方法与应用
CN113508807B (zh) * 2021-08-05 2022-03-04 信阳农林学院 一种卵巢常温保存液及其保存方法
CN114190366B (zh) * 2021-12-29 2023-04-07 松山湖材料实验室 冻存液及其制备方法与在人正常肝细胞的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
CA2041828A1 (en) * 1990-03-05 1992-11-04 Richard L. Lindstrom Viscoelastic solution
EP0516901A1 (de) * 1991-06-06 1992-12-09 Richard L. Lindstrom Methode und Einrichtung für serumlose medizinische Lösung

Also Published As

Publication number Publication date
PT1000541E (pt) 2004-08-31
EP1000541B1 (de) 2004-01-14
AU769082B2 (en) 2004-01-15
AU5710899A (en) 2000-05-11
JP2000198701A (ja) 2000-07-18
CA2288540A1 (en) 2000-05-05
CA2288540C (en) 2011-07-05
US6153582A (en) 2000-11-28
DE69914160D1 (de) 2004-02-19
DE69914160T2 (de) 2004-09-02
EP1000541A1 (de) 2000-05-17
ES2217700T3 (es) 2004-11-01

Similar Documents

Publication Publication Date Title
ATE257648T1 (de) Definierte medizinische lösung ohne serum für die augenheilkunde
DE69114485D1 (de) Definierte medizinische Lösung ohne Serum und deren Verwendung.
Kovačič et al. Influence of atmospheric versus reduced oxygen concentration on development of human blastocysts in vitro: a prospective study on sibling oocytes
US4725586A (en) Surgical solution
Ross et al. Enzymes of the γ-glutamyl cycle in the ciliary body and lens
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
IL190542A0 (en) Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
BR9814568A (pt) "inseminação sexual especìfica de mamìferos com baixo número de células espermatozóides"
CN106854640A (zh) 一种毛囊干细胞的无血清培养基及其制备方法
ES2162331T3 (es) Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea.
US5221537A (en) Tissue irrigating solutions
Marston et al. Time relationships of spermatozoon penetration into the egg of the rhesus monkey
Hassell et al. Increased biosynthesis of specific glycoconjugates in rat corneal epithelium following treatment with vitamin A.
Karlan et al. Potentiation of infections by biomaterials: a comparison of three materials
Boyd Sodium sulfathiazole iontophoresis
Nomura et al. CIII The Capillary in the Human Vestibular Labyrinth: A Histochemical Staining Technique
US5380537A (en) Single irrigating solution used in ocular therapy for the endothelium protection and cornea preservation
Cruz et al. A staging scheme for assessing development in vitro of organogenesis stage embryos of the stripe-faced dunnart, Sminthopsis macroura (Marsupialia: Dasyuridae)
Mössinger In vitro cultivation of adult Litomosoides carinii: evaluation of basic culture media, gas phases and supplements
Pincus Qualitative tests on human enamel protein
US4083991A (en) Topical treatment of herpes infections with thimerosal
Huang et al. Effects of fertilization promoting peptide, adenosine, and pentoxifylline on thawed human sperm
JPH1025201A (ja) 歯牙保存液
Correa-Pérez Embryo transfer medium—hyaluronic acid in place of albumin?
Hull et al. Effect of urokinase on corneal endothelium

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1000541

Country of ref document: EP